Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis

Validation of standardized uptake values for [18F] FDG in 112 lesions at 6 individual organ systems: Comparison of whole-body PET/CT and PET/MRI

Liping Fu, Baixuan Xu and Jiahe Tian
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 232;
Liping Fu
1Department of Nuclear Medicine, The Chinese PLA General Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baixuan Xu
1Department of Nuclear Medicine, The Chinese PLA General Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiahe Tian
1Department of Nuclear Medicine, The Chinese PLA General Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

232

Objectives A recently commercialized integrated PET/MRI has raised intense clinical interest [1-2]. For the clinical applications, especially in oncological indications, the validation of the semi-quantitative measurement (SUVmax) from PET/MRI is essential [3-4]. Therefore, a comparative study between PET/MR and PET/CT was performed to evaluate whether PET/MR could provide a comparable SUVs to that acquired by PET/CT in clinically confirmed FDG-avid lesions at 6 individual organ systems, including head & neck, lung, liver, gastrointestinal system, pancreas and skeletal system.

Methods 150 subjects with various malignancies underwent a single-injection/dual-imaging, IRB approved protocol, consisting of a PET/CT and subsequent PET/MR scan. PET/MR using a sequence combination of T1WI 3D-VIBE, T2WI TSE with fat saturation, DWI with double b values (50 and 800s/mm2), and simultaneous PET acquisition over 45min/5 bed positions. Volumes of interest (VOIs) were drawn over FDG-avid lesions in both MRI based attenuation corrected PET (MRAC-PET) and the corresponding CT based attenuation corrected PET (CTAC-PET) images manually. Pearson correlation analysis and Wilcoxon-Matched-Pairs signed ranks test were used to assess the lesions’ SUVmax derived from PET/CT (SUVmax_CT) and PET/MR (SUVmax_MRI) at various locations.

Results 112 lesions at 6 organs were detected in 150 subjects, including 96 malignant and 7 benign lesions (pathologically confirmed), and 8 malignant and 1 benign lesions (clinical evidence indicated). A strong correlation of SUVmax between PET/CT and PET/MR was observed in six organ systems (R: 0.91 ~ 0.97, Figure 1.). Although no significant difference was detected for lesions in each organ system, the biggest data deviation was found in the lung.

Conclusions PET/MR can provide comparable and feasible measurements as those provided by PET/CT for whole-body examinations.

Research Support This study was financially sponsored by the National Natural Science Foundation of China (grant 30670586, 30900352, 30970770, 30571600 and 60831004),the China Postdoctoral Science Foundation (grant 20090461433) and the Hundred Talents Program of the Chinese Academy of Sciences.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Validation of standardized uptake values for [18F] FDG in 112 lesions at 6 individual organ systems: Comparison of whole-body PET/CT and PET/MRI
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Validation of standardized uptake values for [18F] FDG in 112 lesions at 6 individual organ systems: Comparison of whole-body PET/CT and PET/MRI
Liping Fu, Baixuan Xu, Jiahe Tian
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 232;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Validation of standardized uptake values for [18F] FDG in 112 lesions at 6 individual organ systems: Comparison of whole-body PET/CT and PET/MRI
Liping Fu, Baixuan Xu, Jiahe Tian
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 232;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis

  • Diagnosis value of trimoality PET/CT-MR in digestive tract disease
  • Activity in pulmonary nodules on standard iterative compared to time of flight reconstructed 18F-FDG PET/CT.
  • 11C-acetate PET/CT for prediction of negative lymph node involvement of prostate cancer before prostatectomy
Show more Oncology: Clinical Diagnosis

Oncology General II

  • Interpatient variability of liver SUV in whole body FDG-PET/CT studies
  • Phase II clinical trial to validate usefulness of pioglitazone to differentiate cancerous from inflammatory lesions in patients undergoing FDG PET/CT
Show more Oncology General II

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire